amgen inc said signed letter intent for estimated mln dlr research and development limited partnership fund clinical investigation certain pharmaceutical products currently under development neither terms arrangement nor products covered partnership were disclosed but amgen said limited partnership units will include warrants purchase amgen common stock reuter 